Copertina

Brain‐Derived Tau as an Outcome Marker in Guillain‐Barré Syndrome: A Retrospective Cohort Study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Brynhildur Hafsteinsdóttir, Fernando Gonzalez‐Ortiz, Nina Gleisner, Ellen Alpsten, Jan Lycke, Igal Rosenstein, Lenka Novakova, Kaj Blennow, Tomas Bergström, Henrik Zetterberg, Markus Axelsson
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	European Journal of Neurology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Response to Letter to the Editor Regarding “Brain‐Derived Tau as an Outcome Marker in Guillain‐Barré Syndrome: A Retrospective Cohort Study”
di: Brynhildur Hafsteinsdóttir
Pubblicazione: (2025)

Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis
di: Igal Rosenstein, et al.
Pubblicazione: (2026)

Reassessing BD‐Tau as a Prognostic Biomarker in Guillain‐Barré Syndrome: Methodological Considerations for Clinical Interpretation
di: Umar Aziz
Pubblicazione: (2025)

The Effect of Gadolinium on Synthetic Magnetic Resonance Quantitative Imaging
di: Lenka Novakova, et al.
Pubblicazione: (2025)

Pitfalls in Calculating the Incidence of Guillain‐Barre Syndrome During the Pandemic
di: Josef Finsterer
Pubblicazione: (2025)

Efgartigimod as Add‐On Treatment in Refractory Guillain–Barré Syndrome: A Case Report
di: Paolo Ripellino, et al.
Pubblicazione: (2025)

Efficacy and Safety of Plasmapheresis in Children With Acute Transverse or Flaccid Myelitis, and Guillain‐Barré Syndrome
di: Alix Fleurance, et al.
Pubblicazione: (2025)

Guillain‐Barré syndrome: a comprehensive review
di: Roberto Bellanti, et al.
Pubblicazione: (2024)

Guillain‐Barré syndrome: History, pathogenesis, treatment, and future directions
di: Richard A. C. Hughes
Pubblicazione: (2024)

Guillain‐Barré Syndrome in Gaza Displacement Camps During Gaza War 2023–2025: Prevalence, Risk Factors and Outcomes
di: Zuhair Dardona, et al.
Pubblicazione: (2025)

Increased Cerebrospinal Fluid Adenosine 5′‐Triphosphate Levels in Patients with Guillain–Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
di: Takamasa Nukui, et al.
Pubblicazione: (2024)

Isolated peripheral neuroleukemiosis mimicking Guillain‐Barré syndrome in an adolescent with relapsed B‐lymphoblastic leukemia
di: Ethan Edmondson, et al.
Pubblicazione: (2024)

If it does not help, it might hurt: Pharmacodynamics of a second IVIg course in Guillain–Barré syndrome
di: Sander J. van Tilburg, et al.
Pubblicazione: (2025)

Response to letter on European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain–Barré syndrome
di: Pieter A. van Doorn, et al.
Pubblicazione: (2024)

Vertebral Artery Pseudoaneurysm: Novel Marker of Bow Hunter's Syndrome
di: Joseph Y. Yoon, et al.
Pubblicazione: (2025)

CSF biomarkers of neurotoxicity in childhood cancer survivors after cranial radiotherapy or surgery
di: Erik Fernström, et al.
Pubblicazione: (2024)

Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study
di: Viktor Grut, et al.
Pubblicazione: (2024)

Retrospective In Silico Analysis of Routine Laboratory Data Supports a Specific Association of Epstein–Barr Virus and Multiple Sclerosis
di: Mario Rodomonti, et al.
Pubblicazione: (2025)

Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks
di: Marta Milà‐Alomà, et al.
Pubblicazione: (2025)

Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study
di: Adeline Ngoh, et al.
Pubblicazione: (2025)

Use of Machine Learning to Identify Markers of Risk for Fragile X‐Associated Tremor/Ataxia Syndrome: A Preliminary Analysis
di: Chitrabhanu Gupta, et al.
Pubblicazione: (2026)

The PERISCOPE Cohort: A Retrospective Study of Clinicopathological and TRAF7 Genetic Findings in Intraneural Perineurioma
di: Eduardo Boiteux Uchôa Cavalcanti, et al.
Pubblicazione: (2026)

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis
di: Nicolás Fissolo, et al.
Pubblicazione: (2026)

Clinical and Genetic Heterogeneity of Congenital Myasthenic Syndromes: Insights From a Large Cohort
di: Berk Ozyilmaz, et al.
Pubblicazione: (2025)

Predictive Value of Plasma Biomarkers in Tau‐ PET Transitions
di: Jonathan Graff‐Radford, et al.
Pubblicazione: (2025)

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study
di: Susanna Hallberg, et al.
Pubblicazione: (2024)

Tau Pathology in Alzheimer's Disease Uniquely Affects Sulcal Depths
di: Samira A. Maboudian, et al.
Pubblicazione: (2026)

Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes
di: Hanwen Zhang, et al.
Pubblicazione: (2025)

Increased Blood Levels of NfL , GFAP , and Placental Growth Factor After Radiotherapy to the Brain
di: Erik Fernström, et al.
Pubblicazione: (2025)

Microglial Reactivity Correlates with Presynaptic Loss Independent of β‐Amyloid and Tau
di: Guoyu Lan, et al.
Pubblicazione: (2024)

Robotic Extended Thymectomy in Late‐Onset Myasthenia Gravis: A 21‐Year Retrospective Cohort Study of 172 Patients
di: Luyu Huang, et al.
Pubblicazione: (2025)

A Multi‐Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future Directions
di: Giovanna S. Manzano, et al.
Pubblicazione: (2025)

Iatrogenic Cerebral Amyloid Angiopathy in Patients Treated With Cadaveric Dura Mater During Childhood Neurosurgery: A Retrospective Cohort Study
di: Slaven Pikija, et al.
Pubblicazione: (2025)

High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Study
di: Richard Nicholas, et al.
Pubblicazione: (2024)

The Parkinson's Progression Markers Initiative: Why Then? Why Now?
di: Michael J. Fox
Pubblicazione: (2026)

Epstein–Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein‐Antibody‐Associated Disease
di: Giulia Fadda, et al.
Pubblicazione: (2024)

Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma Biomarkers
di: Christopher A. Brown, et al.
Pubblicazione: (2026)

Circadian Syndrome Mediates the Association Between Body Roundness Index and Incident Stroke Risk in Middle‐Aged and Older Chinese Adults: A Nationwide Prospective Cohort Study
di: Gaiying Ma, et al.
Pubblicazione: (2026)

Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative
di: Lana M. Chahine, et al.
Pubblicazione: (2026)

Return of Individual Research Information in the Parkinson's Progression Markers Initiative
di: Thomas F. Tropea, et al.
Pubblicazione: (2026)